Navin Fluorine’s recent success on new molecule/product launches stems from its in-house R&D at the Surat facility. This new deal is one of them
PRO Only Highlights
– Quarterly performance largely backed by improved realisations
– Medium-term triggers China plus and protectionist measures for tyre industry
– Valuations not inexpensive; but improved medium-term outlook
Navin Fluorine’s (CMP: Rs 3,596; Market Cap: Rs 17,847 crore) subsidiary Navin Fluorine Advanced Sciences Limited (NFASL) has signed an agreement with a large multinational company for ~Rs 800 crore to manufacture an agro-chemical fluoro-intermediate over five years. While this is not the first time the company is announcing a multi-year contract, the R&D pipeline suggests more are in the offing. Nevertheless, FY23 is expected to be a game changer as key specialty projects are expected to roll out from…
